Aprea Therapeutics Inc Sustainability Reports
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel synthetic lethality-based cancer therapeutics targeting DNA damage response pathways.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
3 reports from 2020 to 2024
Company Profile
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel synthetic lethality-based cancer therapeutics targeting DNA damage response pathways.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
